Dr. Xiaodong Wang is the Founding Director & Architect of a 700-person team at the National Institute of Biological Sciences (NIBS) in Beijing. In 2010 he founded BeiGene (NASDAQ: BGNE), a globally focused biopharmaceutical company dedicated to the discovery and development of innovative treatments for cancer. A Howard Hughes Medical Institute Investigator, Dr. Wang served as the George L. MacGregor Distinguished Chair in Biomedical Sciences at the University of Texas Southwestern Medical Center from 1997 to 2010 and as Professor in Biomedical Sciences from 2001 to 2010. He is a member of National Academy of Sciences in the United States and a Foreign Associate of the Chinese Academy of Sciences. Dr. Wang previously founded Joyant Pharmaceuticals, a US-based venture capital-backed oncology biotech, in 2004.
7:30PM, Tuesday, December 19th, 2017
Doors Open at 7:00 pm
Dalio Auditorium, Level B2, Schwarzman College, Tsinghua University
This event is open to Tsinghua students, faculty, and staff.
Please present valid Tsinghua ID Card to access Schwarzman College.
Guests will be admitted until all seating is full.
This lecture will be given in English.